Acute subdural hematoma is a rare presentation of ruptured aneurysms. The rarity of the disease makes it difficult to establish reliable clinical guidelines. Many patients present comatose and differential diagnosis is complicated due to aneurysm rupture results in or mimics traumatic brain injury. Fast decision-making is required to treat this life-threatening condition. Determining initial diagnostic studies, as well as making treatment decisions, can be complicated by rapid deterioration of the patient, and the mixture of symptoms due to the subarachnoid hemorrhage or mass effect of the hematoma. This paper reviews initial clinical and radiological findings, diagnostic approaches, treatment modalities, and outcome of patients presenting with aneurysmal subarachnoid hemorrhage complicated by acute subdural hematoma. Clinical strategies used by several authors over the past 20 years are discussed and summarized in a proposed treatment flowchart.
Introduction
Rupture of a cerebral aneurysm normally results in subarachnoid hemorrhage (SAH) and is often complicated by intracerebral hematoma (ICH), but only on rare occasions does it cause acute subdural hematoma (aSDH) [1] . Diagnosis of aneurysmal SAH can be difficult in comatose patients in whom loss of conscious due to aneurysm rupture results in or mimics a traumatic brain injury [2] . Determining a differential diagnosis and treatment modalities can further be complicated by the rapid clinical course and the mixture of symptoms due to the ruptured aneurysm and the mass effect of the hematoma.
Rapid decision making is required to treat this lifethreatening condition. The majority of patients with aneurysmal SAH and coincidental acute subdural bleeding present in a severe clinical condition, and immediate surgical management is required [2] [3] [4] . Decisions to be made include whether preoperative diagnostic studies should precede surgery and whether obliteration of the aneurysm should be performed during hematoma evacuation or in a separate delayed intervention after resuscitation procedures.
The incidence of combined SAH and aSDH varies from 0.5% [5, 6] to 10% [7] in clinical series. The rarity of aneurysmal aSDH makes it difficult to design reliable clinical treatment guidelines. Large systematic series do not exist, and thus treatment decisions are mainly based on personal experience. The aim of this review is to propose a management flow chart and protocol based on published experience with such cases over the past two decades.
Results
The initial search retrieved 85 publications which matched the terms "cerebral aneurysm" AND "subarachnoid hemorrhage" AND "acute subdural hematoma." 59 publications were excluded after screening of titles and abstracts. This left 26 articles potentially eligible for detailed evaluation. Six articles were not included as they did not match the selection criteria. The remaining 20 articles including 82 cases underwent detailed analysis [2-4, 12-14, 16-26, 28-30] . Characteristics of the 82 cases are summarized in Table 2 . Graphs displaying the analyzed data appear in Figure 1 .
Initial Clinical Findings.
Most of the patients were admitted with the worst initial clinical SAH grades and with signs of uncal herniation. The distribution according to the WFNS was grade 5 (n = 46, 57.3%), grade 4 (n = 14, 17.1%), grade 3 (n = 6, 7.3%), grade 2 (n = 8, 9.8%), and grade 1 (n = 8, 9.8%). At admission, signs of uncal herniation, major focal neurological deficits, and minor focal neurological deficits were present in 35 (42.7%), eight (9.8%), and six (7.3%) patients, respectively. Fourteen (17.1%) patients presented in an unstable cardiopulmonary condition (e.g., ventricular arrhythmia, acute heart failure, and sudden pulmonary edema) at the time of admission. Four (4.9%) patients died during resuscitation. One (1.2%) patient was reported to have had prolonged hypoxia.
Diagnostic Approaches and Radiological Findings.
For all patients, the first radiological assessment was a CT scan (n = 82, 100%). 68 (82.9%) patients underwent additional DSA, and 11 (13.4%) underwent additional CTA ( Figure 2 ). Four (4.9%) patients underwent MRA prior to surgery. SAH was detected on initial CT scan in 68 (82.9%) patients. There were 13 (15.9%) cases of pure aSDH without associated SAH. 28 (34.1%) patients presented with additional ICH. In 24 (29.3%) patients, the size of the aSDH was reported (mean ± SD: 9.6 ± 3.5, range: 5-20 mm). A total of 30 (36.6%) patients were reported as presenting with midline shift associated with aSDH (mean ± SD: 9.1 ± 4.0, range: 4-23 mm). All but six cases (7.3%) of aSDH were documented ipsilateral to the side of the aneurysm. Two cases presented with bilateral aSDH. Aneurysm size was reported in 37 (45.1%) patients (mean ± SD: 11.4±8.1, range: 1.5-30 mm).
Aneurysm Localization.
In most of the cases, the aneurysm was located in the posterior communicating artery (Pcom) (n = 39, 46.6%). The rest of the aneurysms were located in the middle cerebral artery (MCA) (n = 20, 23.2%), the anterior communicating artery (Acom) (n = 11, 13.4%), the pericallosal artery (Pcal) (n = 8, 9.8%), or the internal carotid artery ICA (n = 4, 4.9%).
Treatment Strategies.
The treatment strategies included urgent hematoma evacuation (n = 59, 72%), surgical aneurysm obliteration in the same procedure as urgent hematoma evacuation (n = 41, 50%), delayed clipping (n = 10, 12.2%), and delayed coiling (n = 6, 7.3%). Eighteen patients (22%) died during resuscitation or did not meet the criteria for undergoing any of the invasive procedures due to cardiopulmonary instability. A total of six (7.3%) patients underwent external ventricular drainage, and ten (12.2%) patients were treated with hyperosmolar therapy. outcome (GOS 3 and GOS 2) was reported in nine (11%) patients. 32 patients (26.6%) had fatal outcomes (GOS 1).
Overall distribution according to the GOS was GOS 5 (n = 31, 37.8%), GOS 4 (n = 8, 9.8%), GOS 3 (n = 8, 9.8%), GOS 2 (n = 1, 1.2%), and GOS 1 (n = 32, 39%). In 19 (23.2%) out of 32 patients with fatal outcome (GOS 1), the critical status at admission did not allow any surgical or endovascular intervention. Four (4.9%) patients died during resuscitation, two (2.4%) patients died immediately after diagnosis, and one (1.2%) patient received no further therapy as a result of prolonged hypoxia before admission. Most of the 63 patients who met the criteria for invasive treatment achieved good outcomes (GOS 5 and GOS 4, n = 39, 69.9%). The distribution of these patients by treatment outcome according to the GOS was GOS 5 (n = 31, 49.2%), GOS 4 (n = 8, 12.7%), GOS 3 (n = 8, 12.7%), GOS 2 (n = 1, 1.6%), and GOS 1 (n = 13, 20.6%). Patients who suffered aneurysmal aSDH without SAH demonstrated better outcomes (GOS 5, n = 9, 69.2%; GOS 1, n = 5, 38.5%) than patients who presented with aneurysmal aSDH and SAH (GOS 5, n = 22, 31.4%; GOS 4, n = 8, 11.4%; GOS 3, n = 8, 11.4%; GOS 2, n = 1, 1.4%; GOS 1, n = 27, 38.6%). (Table 3 ). All patients presenting in good clinical condition without rapid neurological deterioration (n = 15) demonstrated good outcomes (GOS 5 and GOS 4). These outcomes were favorable irrespective of whether hematoma evacuation and aneurysm obliteration were immediate (n = 10) or delayed (n = 5). However, patients with rapidly deteriorating levels of consciousness (including signs of brain herniation) and urgent (<24 h) intervention had a higher likelihood of good outcomes (GOS 5 and GOS 4) than patients with rapid deterioration who had undergone delayed (24 h) treatment (64% versus 25%).
Outcome Stratified by Therapeutic Strategies

Discussion
This meta-analysis of 82 reported cases presenting with aneurysmal aSDH and rapid neurological deterioration revealed that urgent surgical decompression and immediate occlusion of the aneurysm seem to be an acceptable treatment strategy in order to achieve better outcome (GOS 5 and GOS 4 = 64%). Good outcomes are found in patients maintaining stable neurological condition irrespective of whether intervention was immediate or delayed (GOS 5 = 100%). Patients with pure aSDH due to a ruptured aneurysm demonstrated better outcomes than patients who suffered aneurysmal aSDH associated with SAH. Patients in unstable cardiopulmonary condition, with unstable blood pressure and serious ventricular arrhythmias, have the highest risk of unfavorable outcomes. All patients who did not meet the criteria for invasive treatment had fatal outcomes. Poor clinical presentation per se is not associated with worse outcome. However, the combination of marginal cardiac output and reduced cerebral perfusion and cerebral blood flow due to the mass effect [31] during the acute phase of SAH [32] is likely to result in poor final outcome. Patients presenting in such condition do not meet the criteria for urgent hematoma evacuation, which additionally worsens the likelihood of favorable outcome (GOS 5 and GOS 4 = 25%). Patients in stable hemodynamic condition are suitable for rapid surgical decompression and maximal medical treatment and have a higher chance of recovering in good neurological condition (GOS 5 and GOS 4 = 64%) despite severe SAH and poor initial GCS admission scores. Twothirds of all patients with either poor grade SAH or traumatic aSDH usually do not survive, and functional outcome is rare [33] [34] [35] . The good recovery of patients with aneurysmal aSDH might be explained by the space-occupying effect of the hematoma, which mimics a worse clinical situation and does not reflect vital brain destruction.
Pure aSDH due to ruptured intracranial aneurysm is extremely rare. Only 20 cases have been reported so far, including 14 cases during the last two decades [16] . In most cases of aneurysmal aSDH, the history will distinguish a traumatic from a spontaneous cause [1] . However, the absence of hematomas and subarachnoid blood collections related to common aneurysm sites can impede the diagnosis. The finding that pure aneurysmal aSDH results in better
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Due to the rarity of the disease, no guidelines have been established. In most reports, patients have bad clinical features on admission, often presenting in a comatose state with pupillary abnormalities. Fast decision making is mandatory. Determining a differential diagnosis, as well as treatment modalities, can be complicated by the rapid clinical course and the mixture of symptoms due to the ruptured aneurysm or mass effect of the hematoma.
To address the lack of guidelines, we developed a flowchart for treatment of patients with aSDH. However, the evidence for the proposed treatment flowchart comes from case series and case reports with relatively small sample sizes. Therefore, the estimation of effects is imprecise, and clinical recommendations included in the management protocol are weak [36, 37] .
In patients who are in good neurological condition at the time of admission, management may proceed in a standard manner ( Figure 3 , left side of the flowchart). After initial CT and CTA examination, DSA is the diagnostic modality of choice to verify the angioarchitecture of the aneurysm. If the aneurysm is suitable for endovascular obliteration and the aSDH remains clinically insignificant, the aneurysm can be occluded during the same procedure [4] . If a decision is made to occlude the aneurysm surgically, DSA provides relevant anatomical information and guidance in determining a clipping strategy and surgical approach.
For the management of patients who are in a coma or whose level of consciousness is deteriorating rapidly, the choice of initial diagnostics is more demanding, and management decisions become difficult (Figure 3 , right side of the flowchart). The aSDH may be the major determinant of neurological grade, and prompt hematoma evacuation may be life saving. At the minimum, neuroradiological investigations should consist of an emergency CT and CTA to visualize potential bleeding sources. Emergency treatment modalities such as maximal sedation, osmotherapy, and external ventricular drainage to reverse signs of brain herniation should be performed as quickly as possible. In these cases, the emergency situation forces the neurosurgeon to postpone DSA.
Intraoperative DSA would allow safe and complete aneurysm occlusion to be carried out at the same time as urgent hematoma evacuation [38, 39] . Patients would be spared a second procedure. However, Westermaier et al. [4] recently presented four patients who underwent separate delayed endovascular coiling after decompression and hematoma evacuation. Despite good neurological recovery in three of these four patients, subjecting patients to two separate procedures rather than clipping at the same time as hematoma removal remains controversial. Patients who present in unstable cardiopulmonary conditions cannot be operated on immediately. It seems that this subgroup of patients is exceptionally at risk of poor outcome. Withholding aggressive therapy in poor-grade patients in order to prevent vegetative survival is highly controversial and cannot be recommended.
Conclusion
Due to the rarity of aneurysmal aSDH, it remains difficult to define a comprehensive management protocol. In patients with poor neurological grade at admission and rapidly deteriorating levels of consciousness, urgent surgical decompression and immediate aneurysm obliteration result in favorable outcome (GOS 5 and GOS 4; 64%). Delay of immediate treatment in patients with rapidly deteriorating neurological conditions decreases the likelihood of a favorable outcome (GOS 5 and GOS 4; 25%). Good outcomes are observed in patients maintaining stable neurological condition irrespective of whether the intervention was immediate or delayed (GOS 5; 100%). Overall outcome of patients who suffered aneurysmal aSDH without SAH proved to be better (GOS 5, 69.2%) than the outcome of patients who presented with aneurysmal aSDH and SAH (GOS 5; 31.4%).
